The bioresorbable polymers market achieved a valuation of US$ 1.3 Billion in 2021 and is anticipated to expand to US$ 6.2 Billion by 2032, exhibiting a robust Compound Annual Growth Rate (CAGR) of 15.8% over the forecast period spanning from 2022 to 2032.

The bioresorbable polymers market has witnessed substantial growth in recent years, driven by advancements in medical technology, increasing demand for biocompatible materials, and a growing focus on sustainable and eco-friendly solutions. Bioresorbable polymers, also known as biodegradable or absorbable polymers, are materials that can be naturally broken down and absorbed by the body over time. These polymers have found diverse applications, particularly in the medical and pharmaceutical sectors.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7974

Market Overview:

The bioresorbable polymers market has experienced robust expansion, with a compound annual growth rate (CAGR) surpassing expectations. This growth is primarily attributed to the rising adoption of bioresorbable materials in medical implants, drug delivery systems, and tissue engineering. These polymers offer several advantages, including reduced inflammation, elimination of the need for removal surgeries, and the ability to support tissue regeneration.

The medical sector, especially orthopedics and cardiology, has emerged as a significant contributor to the bioresorbable polymers market. Bioresorbable polymers are extensively used in the development of implants such as screws, plates, and stents, providing temporary support during the healing process and eventually being absorbed by the body.

Market Opportunity:

The bioresorbable polymers market presents significant opportunities for further expansion. The increasing prevalence of chronic diseases, coupled with a growing aging population, has led to a surge in the demand for advanced medical solutions. Bioresorbable polymers offer a unique advantage in terms of reducing complications associated with traditional permanent implants, providing a lucrative opportunity for market players.

Moreover, ongoing research and development activities are expanding the applications of bioresorbable polymers beyond the medical field. Industries such as packaging and agriculture are exploring the use of these polymers to create environmentally friendly products. The potential to replace traditional plastics with bioresorbable alternatives aligns with the global shift towards sustainability and eco-conscious practices.

Market Challenges:

Despite the promising growth, the bioresorbable polymers market faces challenges that need careful consideration. One of the primary challenges is the complexity associated with the development of bioresorbable materials with optimal mechanical and degradation properties. Achieving the right balance between strength, flexibility, and degradation rate remains a persistent challenge for researchers and manufacturers.

Regulatory hurdles and the need for rigorous testing and validation processes also pose challenges to market players. Ensuring that bioresorbable polymers meet safety and efficacy standards requires significant investments in research and development.

Key Players:

  • Corbion N V
  • Evonik Industries AG
  • Poly-Med, Inc.
  • KLS Martin Group
  • Foster Corporation
  • Ashland Global Holdings Inc.
  • DSM Biomedical, Inc
  • Zeus Industrial Products, Inc
  • REVA Medical, LLC.
  • Poly-Med Incorporated
  • Bezwada Biomedical
  • Nomisma Healthcare Pvt. Ltd.

Competitive Landscape:

In March 2021, Ashland Global Holdings Inc. undertook an expansion of its production plant for Viatel bioresorbable polymer and relocated its research and development (R&D) activities from Dublin to the National Science Park in Mullingar.

In September 2020, Corbion and Total jointly announced their intentions to establish a state-of-the-art polylactic acid bioplastics plant in Europe. This facility, which will be the first of its kind on a global scale in Europe, is projected to have a production capacity of 100 thousand tonnes per year. The new plant is scheduled to commence operations in 2024 and will be situated in France. This strategic investment in polylactic acid will expedite plans to augment lactic acid production and effectively address the growing demand for polymers.

Market Segmentation

  • By Product Type :
    • Biopolyesters
    • Agro-polymers
  • By Application :
    • Orthopedics
    • Drug Delivery
    • Other Applications
  • By Region :
    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7974

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com